Esperion Therapeutics, Inc.
ESPRDelisted Jul 13, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Esperion Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 142 | 1 | 139 | −2 |
| Shares | 28.3M | 131.8K | 24.8M | −3.37M (−11.9%) |
| Value | $599.4M | $2.79M | $299.4M | −$297.2M (−49.8%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Esperion Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 184,684 | $2.23M | 0.01% |
| Pictet Asset Management SA | 131,849 | $1.59M | 0.00% |
| Marshall Wace North America L.P. | 125,953 | $1.52M | 0.01% |
| Linden Advisors LP | 116,827 | $1.41M | 0.01% |
| Russell Investments Group, Ltd. | 94,505 | $1.14M | 0.00% |
| Walleye Trading LLC | 70,324 | $847.0K | 0.02% |
| Aristeia Capital LLC | 67,693 | $816.0K | 0.02% |
| ExodusPoint Capital Management, LP | 63,460 | $765.0K | 0.01% |
| Virginia Retirement Systems Et Al | 48,800 | $588.0K | 0.01% |
| Ergoteles LLC | 48,200 | $581.0K | 0.02% |
| Duality Advisers, LP | 42,213 | $509.0K | 0.04% |
| Jump Financial, LLC | 27,000 | $326.0K | 0.02% |
| Gsa Capital Partners LLP | 23,628 | $285.0K | 0.03% |
| D. E. Shaw & Co., Inc. | 23,079 | $278.0K | 0.00% |
| Jane Street Group, LLC | 16,072 | $194.0K | 0.00% |
| Pinz Capital Management, LP | 15,300 | $184.0K | 0.08% |
| Centiva Capital, LP | 15,038 | $182.0K | 0.01% |
| Independent Advisor Alliance | 11,500 | $139.0K | 0.01% |
| Quantbot Technologies LP | 9,909 | $119.0K | 0.01% |
| Antonetti Capital Management LLC | 2,100 | $25.0K | 0.02% |
| South State Corp. | 314 | $4.00K | 0.00% |
| Signaturefd, LLC | 96 | $1.00K | 0.00% |
| Ellevest, Inc. | 76 | $1.00K | 0.00% |
Sold out (25)
Institutions that held Esperion Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
Not filed for Q3 2021 yet (1)
Institutions that held Esperion Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 131,849 | $2.79M |